Influence of enrollment sequence effect on observed outcomes in the ADDRESS and PROWESS studies of drotrecogin alfa (activated) in patients with severe sepsis

INTRODUCTION: We performed a study to determine whether an enrollment sequence effect noted in the PROWESS (recombinant human activated Protein C Worldwide Evaluation in Severe Sepsis) trial exists in the ADDRESS (Administration of Drotrecogin Alfa [Activated] [DrotAA] in Early Stage Severe Sepsis)...

Descripción completa

Detalles Bibliográficos
Autores principales: Laterre, Pierre-François, Macias, William L, Janes, Jonathan, Williams, Mark D, Nelson, David R, Girbes, Amand RJ, Dhainaut, Jean-François, Abraham, Edward
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592745/
https://www.ncbi.nlm.nih.gov/pubmed/18786266
http://dx.doi.org/10.1186/cc7011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592745/
https://www.ncbi.nlm.nih.gov/pubmed/18786266
http://dx.doi.org/10.1186/cc7011

Ejemplares similares